Overview

Pitocin or Oral Misoprostol for PROM IOL

Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
Premature rupture of membranes (PROM) is a common occurrence of pregnancies at term. A delay from PROM to labor is associated with an increased risk of intrauterine infection and associated maternal and fetal morbidity; therefore, induction of labor (IOL) is recommended. The ideal agent for IOL is not known, particularly among specific subpopulations. The primary aim of this study is to determine if oxytocin (Pitocin) or oral misoprostol results in a shorter interval to delivery after the start of induction among nulliparous women with unfavorable cervical exams with term PROM.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pennsylvania
Treatments:
Misoprostol
Oxytocin